These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3923491)
21. Modification of platelet functions by monobromobimane, a fluorescent thiol group label. Zucker MB; Mauss EA Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818 [TBL] [Abstract][Full Text] [Related]
22. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin. Tandon NN; Ordinas A; Jamieson GA Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815 [TBL] [Abstract][Full Text] [Related]
23. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863 [TBL] [Abstract][Full Text] [Related]
24. Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline. Holmsen H; Day HJ; Setkowsky CA Biochem J; 1972 Aug; 129(1):67-82. PubMed ID: 4675006 [TBL] [Abstract][Full Text] [Related]
25. Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro. Boyd DG; Davis RB Thromb Res; 1988 May; 50(3):429-36. PubMed ID: 3394122 [TBL] [Abstract][Full Text] [Related]
26. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. Smith JB; Ingerman CM; Silver MJ J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533 [TBL] [Abstract][Full Text] [Related]
27. Effects of atorvastatin on ADP-, arachidonic acid-, collagen-, and epinephrine-induced platelet aggregation. Zhao L; Liu D; Liu B; Hu H; Cui W J Int Med Res; 2017 Feb; 45(1):82-88. PubMed ID: 27913744 [TBL] [Abstract][Full Text] [Related]
28. Arginine vasopressin release from human platelets after irreversible aggregation. Anfossi G; Mularoni E; Trovati M; Massucco P; Mattiello L; Emanuelli G Clin Sci (Lond); 1990 Jan; 78(1):113-6. PubMed ID: 2153488 [TBL] [Abstract][Full Text] [Related]
29. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen. Ts'ao C Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732 [TBL] [Abstract][Full Text] [Related]
31. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets. Bertha BG; Sill JC; Berger I; Folts JD; Milde JH Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073 [TBL] [Abstract][Full Text] [Related]
32. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin. Ware JA; Johnson PC; Smith M; Salzman EW J Clin Invest; 1986 Mar; 77(3):878-86. PubMed ID: 3081576 [TBL] [Abstract][Full Text] [Related]
33. Influence of epinephrine on the aggregation response of aspirin-treated platelets. Rao GH; Johnson GJ; White JG Prostaglandins Med; 1980 Jul; 5(1):45-58. PubMed ID: 7403340 [TBL] [Abstract][Full Text] [Related]
34. Optimal conditions for simultaneous measurement of platelet aggregation and ATP secretion in canine whole blood. Jüttner C; Rodríguez M; Fragío C Res Vet Sci; 2000 Feb; 68(1):27-32. PubMed ID: 10684755 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones. Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351 [TBL] [Abstract][Full Text] [Related]
36. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin. Connolly TM; Limbird LE Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431 [TBL] [Abstract][Full Text] [Related]
37. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin. Peerschke EI Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566 [TBL] [Abstract][Full Text] [Related]
38. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion. White JG; Rao GH; Gerrard JM Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276 [TBL] [Abstract][Full Text] [Related]
39. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515 [TBL] [Abstract][Full Text] [Related]
40. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]